SCHEMBL22070521

SCHEMBL22070521

CCOC(=O)CCc1cc(F)c(F)c(OCc2ccc(OC)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 6/20 0.46
▸ CYP4F2 P78329 1/20 0.44
▸ CYP4A11 Q02928 1/20 0.44
▸ MAPT P10636 3/20 0.44
▸ LMNA P02545 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ FFAR4 Q5NUL3 3/20 0.43
▸ APP P05067 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ KMT2A Q03164 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ PPARG P37231 1/20 0.41
▸ PPARD Q03181 1/20 0.41
▸ PPARA Q07869 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ NFKB2 Q00653 1/20 0.41
▸ RELA Q04206 1/20 0.41
▸ MTNR1A P48039 1/20 0.40
▸ MTNR1B P49286 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22070576 0.89 FFAR1 (0.48) FFAR1CYP4F2CYP4A11MAPTLMNA
SCHEMBL3798817 0.87 FFAR4 (0.48) FFAR1CYP4F2CYP4A11LMNAFFAR4
SCHEMBL2350376 0.81 FFAR1 (0.48) FFAR1CYP4F2CYP4A11LMNAFFAR4
SCHEMBL2351289 0.81 FFAR1 (0.53) FFAR1CYP4F2CYP4A11FFAR4APP
SCHEMBL22070810 0.79 LTA4H (0.46) FFAR1APPMTNR1AMTNR1B
SCHEMBL2354053 0.79 FFAR1 (0.56) FFAR1MAPTFFAR4APPALDH1A1
SCHEMBL29641985 0.78 MET (0.50) FFAR1MAOBPPARGPPARDPPARA
SCHEMBL490909 0.78 CYP4F2 (0.70) FFAR1CYP4F2CYP4A11MAPTLMNA
SCHEMBL5687830 0.77 ALOX5 (0.55) CYP4F2CYP4A11ALDH1A1KMT2ANFKB1
SCHEMBL2350411 0.77 FFAR1 (0.53) FFAR1CYP4F2CYP4A11FFAR4APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11365192-B2 Pyridine compound substituted with azole TAISHO PHARMACEUTICAL CO., LTD. (JP) 2022-06-21 — — US disclosed
US-20210122741-A1 PYRIDINE COMPOUND SUBSTITUTED WITH AZOLE TAISHO PHARMACEUTICAL CO., LTD (JP) 2021-04-29 — — US disclosed
EP-3666766-A1 PYRIDINE COMPOUND SUBSTITUTED WITH AZOLE Taisho Pharmaceutical Co., Ltd. (JP) 2020-06-17 — — EP disclosed
CN-110914254-A Azole-substituted pyridine compound 大正制药株式会社 2020-03-24 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210122741-A1 PYRIDINE COMPOUND SUBSTITUTED WITH AZOLE CYP2C19, CYP4A11, CYP11B1 FFAR1 178/4885CYP4F2 20/4885CYP4A11 2/4885
US-11365192-B2 Pyridine compound substituted with azole CYP2C19, CYP4A11, CYP11B1 FFAR1 178/4885CYP4F2 20/4885CYP4A11 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback